Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M134Revenue (TTM) $M15.9Net Margin (%)-151.0Altman Z-Score-52.7
Enterprise Value $M190EPS (TTM) $-0.2Operating Margin %-83.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-158.6Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.2Cash flow > EarningsY
Price/Sales8.35-y EBITDA Growth Rate %4.9Current Ratio0.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-153.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M156ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NAVBJohn Keeley 2015-12-31 Sold Out $1.33 - $2.37
($1.72)
$ 0.86-50%Sold Out0
NAVBJohn Keeley 2015-06-30 Buy $1.24 - $1.67
($1.45)
$ 0.86-41%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NAVB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-12-01Sell12,500$1.5-41.33view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-11-02Sell12,500$1.98-55.56view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-10-01Sell12,500$2.27-61.23view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.88-53.19view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.71-48.54view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.24-29.03view
Troup Gordon ADirector 2015-05-29Buy10,000$1.31-32.82view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.31-32.82view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.33-33.83view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-44.3view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 

More From Other Websites
Navidea Provides Financing Update May 23 2016
6:57 am Navidea Biopharma receives an unsolicited offer from an insitutional investor to refinance... May 23 2016
Navidea Provides Financing Update May 23 2016
Edited Transcript of NAVB earnings conference call or presentation 17-May-16 12:00pm GMT May 18 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 17 2016
Navidea Reports First Quarter 2016 Financial Results May 17 2016
Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today May 17 2016
Q1 2016 Navidea Biopharmaceuticals Inc Earnings Release - Before Market Open May 17 2016
Navidea Reports First Quarter 2016 Financial Results May 17 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 16 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers May 13 2016
Navidea Biopharmaceuticals to Announce First Quarter 2016 Financial Results on May 17, 2016 May 10 2016
Navidea Biopharmaceuticals to Announce First Quarter 2016 Financial Results on May 17, 2016 May 10 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers,... May 10 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant,... May 09 2016
Tobii AB Earnings Call scheduled for 4:30 pm ET today May 05 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a... May 03 2016
Navidea and Macrophage Therapeutics to Provide Development Program Update May 03 2016
Navidea and Macrophage Therapeutics to Provide Development Program Update May 03 2016
Navidea Appoints Jed Latkin as Interim Chief Operating Officer Apr 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)